Wendy Mao

832 total citations
8 papers, 342 citations indexed

About

Wendy Mao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Wendy Mao has authored 8 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Wendy Mao's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (3 papers) and CAR-T cell therapy research (2 papers). Wendy Mao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (3 papers) and CAR-T cell therapy research (2 papers). Wendy Mao collaborates with scholars based in United States and Japan. Wendy Mao's co-authors include Charles G. Drake, Ali Ghasemzadeh, Zoila A. Lopez‐Bujanda, Thomas R. Nirschl, Matthew G. Chaimowitz, Aleksandar Obradović, Yuki Muroyama, Christopher J. Thoburn, Alan K. Meeker and Christina M. Kochel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Wendy Mao

8 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy Mao United States	5	226	181	97	81	40	8	342
Yuki Muroyama United States	5	241 1.1×	181 1.0×	50 0.5×	52 0.6×	30 0.8×	10	330
Houssein Abdul Sater United States	11	373 1.7×	298 1.6×	122 1.3×	81 1.0×	41 1.0×	33	513
Jean‐Nicolas Lodewyckx Belgium	4	351 1.6×	277 1.5×	86 0.9×	63 0.8×	56 1.4×	7	455
Arianna Draghi Denmark	12	316 1.4×	287 1.6×	111 1.1×	58 0.7×	32 0.8×	28	458
Lillian Sun United States	7	378 1.7×	298 1.6×	120 1.2×	63 0.8×	36 0.9×	9	508
Ahmed Raji Iraq	3	204 0.9×	132 0.7×	97 1.0×	68 0.8×	42 1.1×	8	319
Carla Costa-Nunes Switzerland	3	381 1.7×	368 2.0×	87 0.9×	44 0.5×	33 0.8×	3	483
Teppei Yamada Japan	11	239 1.1×	164 0.9×	81 0.8×	52 0.6×	25 0.6×	28	364
Alfons JM van den Eertwegh Netherlands	7	420 1.9×	381 2.1×	96 1.0×	107 1.3×	22 0.6×	8	546
Stephanie O. Dudzinski United States	5	126 0.6×	132 0.7×	68 0.7×	46 0.6×	48 1.2×	12	268

Countries citing papers authored by Wendy Mao

Since Specialization

Citations

This map shows the geographic impact of Wendy Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Mao more than expected).

Fields of papers citing papers by Wendy Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Mao. The network helps show where Wendy Mao may publish in the future.

Co-authorship network of co-authors of Wendy Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Mao. A scholar is included among the top collaborators of Wendy Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Mao. Wendy Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

McCann, Patrick J., Wendy Mao, Matthew G. Chaimowitz, et al.. (2023). Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC). Cancer Research. 83(11_Supplement). B032–B032. 1 indexed citations

Mao, Wendy. (2022). Overcoming current challenges to T-cell receptor therapy via metabolic targeting to increase antitumor efficacy, durability, and tolerability. Frontiers in Immunology. 13. 1056622–1056622. 8 indexed citations

Aggen, David H., Casey R. Ager, Aleksandar Obradović, et al.. (2020). Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses. Clinical Cancer Research. 27(2). 608–621. 92 indexed citations

Spina, Catherine S., Chizuru Tsuruoka, Wendy Mao, et al.. (2020). Differential Immune Modulation With Carbon-Ion Versus Photon Therapy. International Journal of Radiation Oncology*Biology*Physics. 109(3). 813–818. 20 indexed citations

Mao, Wendy, Ali Ghasemzadeh, Zachary T. Freeman, et al.. (2019). Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition. Journal for ImmunoTherapy of Cancer. 7(1). 277–277. 50 indexed citations

Spina, Catherine S., Zoila A. Lopez‐Bujanda, Wendy Mao, et al.. (2019). Radiation Induces a Dose-Dependent Increase in Immunosuppressive Myeloid Cells in Solid Tumors. International Journal of Radiation Oncology*Biology*Physics. 105(1). S124–S125. 2 indexed citations

Aggen, David H., Ali Ghasemzadeh, Wendy Mao, et al.. (2019). Preclinical development of combination therapy targeting the dominant cytokine interleukin-1β for renal cell carcinoma.. Journal of Clinical Oncology. 37(15_suppl). e14237–e14237. 3 indexed citations

Muroyama, Yuki, Thomas R. Nirschl, Christina M. Kochel, et al.. (2017). Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. Cancer Immunology Research. 5(11). 992–1004. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact